Add like
Add dislike
Add to saved papers

Time Trends in Incidence and Mortality of Cutaneous Melanoma in Germany.

OBJECTIVES: To characterize incidence and mortality trends of cutaneous melanoma (CM) in Germany to extrapolate these data until 2030.

METHODS: We evaluated data from the Centre for Cancer Registry Data (1999-2012), and from the Saarland cancer registry (1970-2012). Age standardized (according to the European Standard Population, WHO 1976) incidence and mortality rates (ASIRs, ASMRs) and crude incidence and mortality rates (CIRs, CMRs) were analyzed.

RESULTS: In entire Germany, ASIRs increased by 55% to 19.2 and CIRs by 77% to 26.0 new cases per 100,000 from 1999-2012. ASMRs remained stable, whereas CMR increased by 58% to 4.1 for males, and by 30% to 3.0 for females per 100,000. In the Federal State of Saarland ASIRs increased more than 4 fold to 13.1, CIRs increased 6-7 fold to 18.5/100,000 from 1970-2012. In the same period, ASMRs increased 3 fold in males and 2 fold in females to 2.5 and 1.6, whereas CMRs increased 5.5 fold in males and 3.5 fold in females to 3.9 and 3.2/100,000, mainly caused by steep increases of CIRs and CMRs in age groups ≥60 years. Projected CIRs will rise to 44-46 for males and 38-40 for females in 2030. Steepest increases were extrapolated for patients ≥60 years, especially for males, but are also expected for age groups of 40-59 years. In contrast CIRs are anticipated to stabilize for subjects <40 years.

CONCLUSIONS: There is a constant increase of incidence and mortality rates for CM in Germany. As the German population is ageing and the current population has already accumulated high levels of UV exposure, a further increase in melanoma incidence, is projected for the future without signs of leveling-off. This article is protected by copyright. All rights reserved.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app